Clinical Trial Update: Stimulation With Bethanechol in Combination With Gemcitabine and Nab-paclitaxel in Pancreatic Adenocarcinoma [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial evaluating stimulation with bethanechol in combination with gemcitabine and nab-paclitaxel for pancreatic adenocarcinoma. The study is …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Pancreatic Adenocarcinoma

Drugs mentioned

• Abraxane (paclitaxel albumin-bound)
• Bethanechol (bethanechol)
• Gemzar (gemcitabine)

Snippet

Sponsor: Susan E. Bates | Conditions: Pancreas Cancer | Phase 2 | Status: RECRUITING